Beam Therapeutics Inc (BEAM)
23.13
+0.41
(+1.80%)
USD |
NASDAQ |
May 03, 16:00
23.12
-0.01
(-0.04%)
After-Hours: 20:00
Beam Therapeutics Shares Outstanding: 81.66M for Feb. 20, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 20, 2024 | 81.66M |
December 31, 2023 | 81.63M |
November 01, 2023 | 81.50M |
October 27, 2023 | 81.20M |
September 30, 2023 | 79.38M |
August 01, 2023 | 79.20M |
June 30, 2023 | 77.95M |
May 03, 2023 | 76.22M |
April 10, 2023 | 74.68M |
March 31, 2023 | 74.44M |
February 22, 2023 | 72.40M |
December 31, 2022 | 71.28M |
October 31, 2022 | 70.47M |
September 30, 2022 | 70.46M |
August 02, 2022 | 70.35M |
June 30, 2022 | 70.31M |
May 02, 2022 | 70.27M |
April 11, 2022 | 70.17M |
March 31, 2022 | 69.75M |
February 22, 2022 | 68.73M |
December 31, 2021 | 68.39M |
November 01, 2021 | 68.14M |
September 30, 2021 | 67.73M |
August 03, 2021 | 66.35M |
Date | Value |
---|---|
June 30, 2021 | 64.45M |
June 10, 2021 | 62.93M |
May 04, 2021 | 62.58M |
April 12, 2021 | 62.54M |
March 31, 2021 | 61.74M |
March 15, 2021 | 61.63M |
March 08, 2021 | 62.42M |
January 21, 2021 | 61.21M |
January 16, 2021 | 58.42M |
December 31, 2020 | 57.25M |
November 06, 2020 | 57.97M |
October 30, 2020 | 55.89M |
October 05, 2020 | 55.14M |
September 30, 2020 | 50.44M |
August 31, 2020 | 50.14M |
August 04, 2020 | 51.73M |
June 30, 2020 | 49.65M |
May 08, 2020 | 51.49M |
March 31, 2020 | 49.08M |
March 25, 2020 | 51.34M |
March 13, 2020 | 51.33M |
February 11, 2020 | 51.25M |
February 06, 2020 | 49.66M |
January 27, 2020 | 45.32M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
45.32M
Minimum
Jan 27 2020
81.66M
Maximum
Feb 20 2024
64.55M
Average
65.40M
Median
Shares Outstanding Benchmarks
Eli Lilly and Co | 950.41M |
Moderna Inc | 383.24M |
Editas Medicine Inc | 81.81M |
Intellia Therapeutics Inc | 96.11M |
Perspective Therapeutics Inc | 586.92M |